via Queen’s University Belfast
Scientists at Queen’s University Belfast have discovered a new molecule which has the potential to prolong the life of individuals with cystic fibrosis (CF).
The molecule represents a possible future treatment and works by altering cellular ion channels resulting in improved airway hydration and significantly increased mucus clearance.
For individuals with CF, normal airway clearance mechanisms which keep the lungs free of infection are defective. As a result, a build-up of mucus occurs and predisposes the individual to chronic bacterial infection. The ensuing cycles of chronic infection and airway inflammation cause progressive destruction of the airways, which is ultimately fatal.
The innovative approach could reduce the frequency of these infections through a novel protease inhibitor which prevents activation of the epithelial sodium channel; ENaC.
The research involved a team of scientists from Queen’s University alongside colleagues at the Royal College of Surgeons in Ireland and the University of North Carolina, and was funded by The Cystic Fibrosis Trust.
Speaking about the breakthrough, Dr Lorraine Martin from the School of Pharmacy at Queen’s University Belfast, said: “This is an important finding which could provide a novel therapeutic opportunity relevant to all individuals with CF, as the targeting of ENaC is independent of their underlying CF mutation. This strategy could prevent the significant lung damage that results from chronic cycles of infection and inflammation, with potential impact on quality of life as well as life expectancy. This is a further example of Queen’s University’s research advancing knowledge and changing lives.”
Ed Owen, Chief Executive at the Cystic Fibrosis Trust, said: “We are thrilled with these initial findings and are excited to see how the next stage of preclinical testing progresses. We are pleased to have been able to fund this world class project at its early stage and welcome the drug development programme planned over the coming years. Research is the biggest single area of investment for the Cystic Fibrosis Trust and it’s wonderful to see projects like this making such positive progress in our fight for a life unlimited.”
Currently available pharmacological alternatives are only suitable for a small subset of patients depending on the disease-causing genetic mutation.
Learn more: QUEEN’S SCIENTISTS DEVELOP NEW TREATMENT TO PROLONG LIFE OF THOSE WITH CYSTIC FIBROSIS
The Latest on: Cystic Fibrosis
via Google News
The Latest on: Cystic Fibrosis
- Community’s show of support for six year old with Cystic Fibrosison January 17, 2021 at 6:20 am
The Pittsworth community has thrown its support behind a fundraising event for Evie Smith, a six year old girl in need of a double lung transplant. Pittsworth couple Barry and Deb Standing have always ...
- In Philly, only certain health problems get you to the front of the COVID-19 vaccine lineon January 16, 2021 at 2:24 am
Spraker has seen a friend face-to-face. She suffers from Addison’s disease, a rare autoimmune condition that affects the adrenal glands, and her fears of what might happen if she contracts COVID-19 ...
- Drag star uses shows to raise awareness of cystic fibrosison January 14, 2021 at 3:45 am
Jordan McKinley may have cystic fibrosis but, as a teenager, discovered a love of drag and became artist Jordy Deelight. Despite spending years in and out of hospital, Jordy has not let their ...
- Eloxx Pharmaceuticals Announces Cystic Fibrosis Foundation (CF Foundation) To Provide Increased ...on January 13, 2021 at 10:57 pm
The CF Foundation’s partial funding of the U.S. trial has been extended to partial funding of the global clinical trial program which includes Europe and Israel Expect to report top line data from our ...
- Cystic Fibrosis Market Size, Revenue, Demand, Shares, Analysis and Forecasts to 2025on January 13, 2021 at 10:37 am
Information By Treatment Method (Medication, Devices, Others) and By Region (North America, Europe, Asia-Pacific and the Middle East & Africa) – Forecast till 2025 According to a recent study report ...
- Medicare Coverage for Cystic Fibrosis: Testing, Management, and Treatmentson January 12, 2021 at 1:31 pm
Medicare covers the testing, treatment, and care you need for cystic fibrosis. Find out exactly what's covered by the different parts of Medicare.
- Vertex Pharma taking more aggressive M&A stance, flush with cash from cystic fibrosis drugson January 11, 2021 at 8:40 am
With its balance sheet growing with cash from its cystic fibrosis drugs, Vertex has the “financial firepower” to consider deals, CEO says.
- Benefits of 'transformational' cystic fibrosis drug highlighted in new reviewon January 11, 2021 at 6:22 am
A new systematic review by University of Liverpool researchers highlights the positive impact that triple-combination therapy has on the wellbeing of people with Cystic Fibrosis (CF).
- Machine learning comes of age in cystic fibrosison January 8, 2021 at 7:18 am
World-leading AI technology developed by the Cambridge Centre for AI in Medicine and their colleagues offers a glimpse of the future of precision medicine, and unprecedented predictive power to ...
- Supermarket worker awarded compensation after foot injury led to aggravation of cystic fibrosison January 4, 2021 at 9:41 pm
A worker who suffers cystic fibrosis has been awarded compensation for a lung transplant he needed as a result of a foot injury while at work, despite not telling his employer of his long term illness ...
via Bing News
. Th){kind=link}